Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The propose of this study is to determine if neoadjuvant chemotherapy followed by
chemoradiation is safe and effective in locally advanced cervical cancer patients. Moreover,
the study would determine if there is any association between hENT1 expression and response
rate to gemcitabine.
Phase:
Phase 2
Details
Lead Sponsor:
Professor Fernando Figueira Integral Medicine Institute